Kohei Miyazono Selected Research

Bone Morphogenetic Protein 7

12/2004	BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells.
2/2003	Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kohei Miyazono Research Topics

Disease

98	Neoplasms (Cancer) 03/2022 - 01/2002
14	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2004
14	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2005
12	Carcinogenesis 01/2022 - 02/2003
11	Carcinoma (Carcinomatosis) 01/2019 - 12/2004
8	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 02/2004
8	Fibrosis (Cirrhosis) 08/2018 - 02/2007
6	Glioma (Gliomas) 01/2022 - 11/2009
5	Inflammation (Inflammations) 01/2021 - 07/2007
5	Myositis Ossificans (Fibrodysplasia Ossificans Progressiva) 01/2021 - 12/2008
5	Hepatocellular Carcinoma (Hepatoma) 11/2019 - 02/2003
5	Stomach Neoplasms (Stomach Cancer) 03/2014 - 02/2003
4	Adenocarcinoma of Lung 07/2018 - 04/2009
4	Prostatic Neoplasms (Prostate Cancer) 02/2016 - 12/2004
4	Adenocarcinoma 01/2011 - 02/2007
4	Pathologic Processes 01/2011 - 10/2008
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2018
3	Kidney Neoplasms (Kidney Cancer) 08/2021 - 01/2018
3	Vascular Diseases (Vascular Disease) 11/2019 - 10/2002
3	Glioblastoma (Glioblastoma Multiforme) 11/2019 - 07/2011
3	Lung Neoplasms (Lung Cancer) 02/2012 - 04/2009
2	Triple Negative Breast Neoplasms 03/2022 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 01/2004
2	Hereditary Hemorrhagic Telangiectasia 11/2013 - 12/2002
2	Peritonitis 05/2008 - 11/2007
2	Bone Resorption 02/2008 - 04/2004
2	Familial Primary Pulmonary Hypertension 12/2004 - 09/2002
1	Ovarian Neoplasms (Ovarian Cancer) 11/2021
1	Endometrial Neoplasms (Endometrial Cancer) 07/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Mouth Neoplasms (Oral Cancer) 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Pulmonary Arterial Hypertension 11/2019
1	Brain Neoplasms (Brain Tumor) 11/2019

Drug/Important Bio-Agent (IBA)

37	Transforming Growth Factor beta (TGF-beta)IBA 06/2019 - 01/2002
31	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2022 - 03/2003
17	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2022 - 09/2002
15	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2003
9	MicroRNAs (MicroRNA)IBA 09/2015 - 07/2009
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2004
8	CytokinesIBA 01/2021 - 10/2008
7	LigandsIBA 03/2022 - 04/2002
6	Phosphotransferases (Kinase)IBA 01/2018 - 12/2004
6	Messenger RNA (mRNA)IBA 05/2015 - 11/2007
5	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2019 - 02/2003
5	Transcription Factors (Transcription Factor)IBA 01/2018 - 04/2002
5	Transforming Growth Factor-beta Type I ReceptorIBA 12/2008 - 12/2002
4	RNA (Ribonucleic Acid)IBA 11/2021 - 01/2017
4	Activin Receptors (Activin Receptor)IBA 01/2021 - 11/2013
4	Pharmaceutical PreparationsIBA 05/2020 - 04/2010
3	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2021 - 05/2012
3	Epidermal Growth Factor (EGF)IBA 01/2020 - 06/2003
3	Protein Isoforms (Isoforms)IBA 01/2020 - 01/2016
3	Growth Differentiation Factor 2IBA 01/2017 - 05/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 07/2008
3	Type I Bone Morphogenetic Protein ReceptorsIBA 01/2017 - 12/2004
3	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 06/2011 - 12/2002
3	MicellesIBA 01/2011 - 12/2008
2	Cadherins (E-Cadherin)IBA 01/2022 - 04/2009
2	ChemokinesIBA 01/2021 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 02/2003
2	Activins (Activin)IBA 01/2019 - 04/2002
2	Aldehyde DehydrogenaseIBA 01/2018 - 05/2015
2	Therapeutic UsesIBA 01/2017 - 01/2011
2	Peptides (Polypeptides)IBA 02/2016 - 01/2011
2	Biological ProductsIBA 02/2016 - 12/2009
2	Doxycycline (Periostat)FDA LinkGeneric 07/2011 - 12/2004
2	AndrogensIBA 03/2011 - 12/2004
2	Estrogens (Estrogen)FDA Link 03/2011 - 04/2004
2	Lysine (L-Lysine)FDA Link 01/2011 - 12/2008
2	DisulfidesIBA 01/2011 - 04/2010
2	Ethylene Glycol (Monoethylene Glycol)IBA 01/2011 - 12/2008
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 04/2010 - 04/2009
2	Thrombospondin 1IBA 10/2009 - 04/2009
2	Transforming Growth Factor-beta Type II ReceptorIBA 10/2009 - 04/2009
2	Vascular Endothelial Growth Factor CIBA 05/2008 - 11/2007
2	4- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA 10/2007 - 11/2003
2	Bone Morphogenetic Protein 7IBA 12/2004 - 02/2003
2	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 12/2004 - 09/2002
1	InterferonsIBA 03/2022
1	Red Fluorescent ProteinIBA 01/2022
1	DNA Methyltransferase 3AIBA 01/2022
1	Cytochromes c (Cytochrome c)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 09/2021
1	EndoglinIBA 08/2021
1	SR 48692IBA 01/2021
1	Cell Surface ReceptorsIBA 01/2021
1	PyrazolesIBA 01/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021
1	NeurotensinIBA 01/2021
1	Neurotensin Receptors (Neurotensin Receptor)IBA 01/2021
1	pyrazoleIBA 05/2020
1	EphA1 Receptor (Eph Receptor)IBA 11/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2019

Therapy/Procedure

11	Therapeutics 03/2022 - 02/2007
3	Drug Therapy (Chemotherapy) 01/2016 - 11/2009
2	Transplantation 01/2021 - 11/2010